164P Preliminary results from a phase I/II study of BDC-1001, a novel HER2 targeting TLR7/8 immune-stimulating antibody conjugate (ISAC), in patients (pts) with advanced HER2-expressing solid tumors
| Autor: | M.R. Sharma, R.D. Carvajal, G.J. Hanna, Y.K. Kang, J. Lee, K.W. Lee, B.T. Li, K.N. Moore, M. Pegram, D. Rasco, A. Spira, D. Wang, B.A. Weinberg, M. Alonso, L. Fang, A. Husain, M. Kowanetz, E.A. Perez, E.I. Dumbrava |
|---|---|
| Rok vydání: | 2021 |
| Předmět: | |
| Zdroj: | Annals of Oncology. 32:S1453-S1454 |
| ISSN: | 0923-7534 |
| DOI: | 10.1016/j.annonc.2021.10.183 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|